label int64 1 1 | id stringlengths 10 12 | original_id stringlengths 8 9 | text stringlengths 347 29.5k |
|---|---|---|---|
1 | 171815589_2 | 171815589 | to be registered pursuant to Section 12(b) of the Act.
Title of each class Common shares value $ 1.20 per share
Name of each exchange on which registered NYSE
Securities registered or to be registered pursuant to Section 12(g) of the Act. None
Securities for which there is a reporting obligation pursuant to Secti... |
1 | 171815589_3 | 171815589 | Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes ¨ No
Indicate by check mark whether the registrant has submitted electronically and posted on its cor... |
1 | 171815589_b0 | 171815589 | 's knowledge, that:
The annual report on Form 20-F for the year ended December 31, 2016 (the "Report") of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Report fairly presents, in all material respects, the financial... |
1 | 171815589_b1 | 171815589 | of title 18, United States Code), the undersigned officer of Globant S.A (the "Company"), hereby certifies, to such officer's knowledge, that:
The annual report on Form 20-F for the year ended December 31, 2016 (the "Report") of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securiti... |
1 | 171838485_0 | 171838485 | TRINITY BIOTECH PLC
Form 20-F
Filed on 24-Apr-2017 Period 31-Dec-2016 Accession number: 0001193125-17-133793
Included Items
1. 20-F: FORM 20-F 2. EX-12.1 3. EX-12.2 4. EX-13.1 5. EX-13.2 6. EX-15.1
Table of Contents
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 20-F
REGISTRATION STATEMENT PURSUA... |
1 | 171838485_1 | 171838485 | THESECURITIES EXCHANGEACT OF 1934
Date of event requiring this shell company report
Commission file number: 0-22320
Trinity Biotech plc
(Exact name of Registrant as specified in its charter and translation of Registrant's name into English)
Ireland (Jurisdiction of incorporation or organization)
IDA Business Park... |
1 | 171838485_2 | 171838485 | (d) of the Act: None
Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report:
96,162,410 Class `A' Ordinary Shares (as of December 31, 2016)
Indicate by check mark if the registrant is a well-known seasoned issuer... |
1 | 171838485_3 | 171838485 | be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated file... |
1 | 171838485_b0 | 171838485 | c for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.
Exhibit 13.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Trinity Biotech plc (the "Company") on Form 20-F for the period en... |
1 | 171838485_b1 | 171838485 | Company") on Form 20-F for the period ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Ronan O'Caoimh, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1... |
1 | 171853290_0 | 171853290 | Merus N.V.
Form 20-F
Filed on 28-Apr-2017 Period 31-Dec-2016 Accession number: 0001193125-17-148152
Included Items
1. 20-F 2. EX-1.1 3. EX-4.1 4. EX-4.2 5. EX-4.3 6. EX-4.12 7. EX-4.13 8. EX-12.1 9. EX-12.2 10. EX-13.1 11. EX-13.2 12. EX-15.1
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHI... |
1 | 171853290_1 | 171853290 | ) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
to
OR
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
Commission file number 001-37773
MERUS N.V.
(Exact name of Registrant as specified in its cha... |
1 | 171853290_2 | 171853290 | on which registered The Nasdaq Stock Market LLC
Securities registered or to be registered pursuant to Section 12(g) of the Act. None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act. None
Indicate the number of outstanding shares of each of the issuer's classes of capital or... |
1 | 171853290_3 | 171853290 | ) has been subject to such filing requirements for the past 90 days Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this ... |
1 | 171853290_b0 | 171853290 | December 31, 2016 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: April 28,... |
1 | 171853290_b1 | 171853290 | directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial informati... |
1 | 171855299_0 | 171855299 | MATERIALISE NV
Form 20-F
Filed on 01-May-2017 Period 31-Dec-2016 Accession number: 0001193125-17-149080
Included Items
1. 20-F 2. EX-8.1 3. EX-12.1 4. EX-12.2 5. EX-13.1 6. EX-13.2 7. EX-23.1
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
REGISTRATION STATEMEN... |
1 | 171855299_1 | 171855299 | Number: 001-36515
MATERIALISE NV
(Exact name of Registrant as specified in its charter)
Not Applicable
(Translation of Registrant's name into English)
Kingdom of Belgium
(Jurisdiction of incorporation or organization)
Technologielaan 15, 3001 Leuven, Belgium
(Address of principal executive offices)
Peter Leys, tele... |
1 | 171855299_2 | 171855299 | or to be registered pursuant to Section 12(g) of the Act: None.
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None.
The number of outstanding shares of each of the issuer's classes of capital or common stock as of December 31, 2016 was: 47,325,438 Ordinary Shares Indicate ... |
1 | 171855299_3 | 171855299 | if any, every Interactive Data File required to be submitted and
posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No
Indicate by check mark whether the registrant i... |
1 | 171855299_b0 | 171855299 | S. Securities Exchange Act of 1934, as amended and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: April 28, 2017
By: /s/ Wilfried Vancraen Wilfried Vancraen Chief Executive Officer
EXHIBIT 13.2
CERTIFICATI... |
1 | 171855299_b1 | 171855299 | Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over financial reporting.
Date: April 28, 2017
By: /s/ Johan Albrecht Johan Albrecht Alfinco BVBA Chief Financial Officer
EXHIBIT 13.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECT... |
1 | 171855588_0 | 171855588 | NATUZZI S P A
Form 20-F
Filed on 01-May-2017 Period 31-Dec-2016 Accession number: 0001193125-17-150051
Included Items
1. 20-F: FORM 20-F 2. EX-4.6 3. EX-4.7 4. EX-8.1 5. EX-12.1 6. EX-12.2 7. EX-13.1
Table of Contents
Natuzzi S.p.A
Annual Report on Form 20-F 2016
Table of Contents
UNITED STATES SECURITIES AND E... |
1 | 171855588_1 | 171855588 | 70029, Santeramo in Colle, Bari, Italy
(Address of principal executive offices)
Mr. Pietro Direnzo Tel.: +39 080 8820 812; pdirenzo@natuzzi.com; Via Iazzitiello 47, 70029 Santeramo in Colle, Bari, Italy
(Name, telephone, e-mail and/or facsimile number and address of company contact person)
Securities registered or to ... |
1 | 171855588_2 | 171855588 | 2016 54,853,045 Ordinary Shares
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) ... |
1 | 171855588_3 | 171855588 | check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer Non-accelerated ... |
1 | 171855588_b0 | 171855588 | affected, or is reasonably likely to materially affect, the company's internal control over financial reporting and
5. The company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company's auditors and the audit committee of t... |
1 | 171855588_b1 | 171855588 | maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure co... |
1 | 171857443_0 | 171857443 | Ternium S.A.
Form 20-F
Filed on 01-May-2017 Period 31-Dec-2016 Accession number: 0001615774-17-001967
Included Items
1. 20-F 2. EX-8.1: EXHIBIT 8.1 3. EX-12.1: EXHIBIT 12.1 4. EX-12.2: EXHIBIT 12.2 5. EX-13.1: EXHIBIT 13.1 6. EX-13.2: EXHIBIT 13.2
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20... |
1 | 171857443_1 | 171857443 | of 1934
Commission file number: 001-3132734
TERNIUM S.A.
(Exact name of Registrant as specified in its charter)
N/A (Translation of Registrant's name into English)
Grand Duchy of Luxembourg (Jurisdiction of incorporation or organization)
29, Avenue de la Porte-Neuve 3rd floor L-2227 Luxembourg
(Address of principal ... |
1 | 171857443_2 | 171857443 | trading but only in connection with the registration of American Depositary Shares which are evidenced by American Depositary Receipts.
Securities registered or to be registered pursuant to Section 12(g) of the Act: None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
... |
1 | 171857443_3 | 171857443 | rant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indi... |
1 | 171857443_b0 | 171857443 | "Company"), hereby certifies, to such officer's knowledge, that the Company's Annual Report on Form 20-F for the year ended December 31, 2016 (the "Report"), fully complies with the requirements of section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and the information contained in the Report... |
1 | 171857443_b1 | 171857443 | (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company's ability to record, process, summarize and report financial information and
(... |
1 | 171858649_0 | 171858649 | Ferroglobe PLC
Form 20-F
Filed on 01-May-2017 Period 31-Dec-2016 Accession number: 0000950157-17-000524
Included Items
1. 20-F 2. EX-4.6 3. EX-4.7 4. EX-4.10 5. EX-4.11 6. EX-4.35 7. EX-12.1 8. EX-12.2 9. EX-13.1 10. EX-16.1 11. EX-23.1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 2... |
1 | 171858649_1 | 171858649 | OR
SHELL COMPANYREPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934 Commission file number: 001-37668
Ferroglobe PLC
(Exact name of Registrant as specified in its charter)
England and Wales (Jurisdiction of incorporation or organization)
2nd Floor West Wing, Lansdowne House 57 Berkeley Squa... |
1 | 171858649_2 | 171858649 | (g) of the Act. None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act. None
Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report.
Ordinary Shares (nominal value of $0.01... |
1 | 171858649_3 | 171858649 | for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File requi... |
1 | 171858649_b0 | 171858649 |
0
NO
NO
1
0 $
540
0
NO
NO
0
0 $
0
0
NO
NO
0
0 $
0
0
NO
NO
0
0 $ 447.00
0
NO
NO
0
0 $ 138.00
0
NO
NO
2
0 $ 100.00
0
NO
NO
0
Legal Actions Initiated During
the Period
(#)
9
0
0
54
22
0
0
0
0
0
3
1
1
Legal Actions Resolved During Period
(#)
9
0
0
52
28
0
0
0
0
0
3
4
1
(A) The pendin... |
1 | 171858649_b1 | 171858649 |
0
0
0
0
0
0
0
0
0
Section 107(a) Orders
(#)
Total Dollar Value of MSHA
Assessments Proposed ($)
Total Number
of Mining Related Fatalities
(#)
Received Notice of Pattern of Violations
Under Section 104(e) (yes/no)
Received Notice of Potential to Have Pattern
Under Section 104(e) (yes/no)
Legal Actions Pen... |
1 | 171902242_0 | 171902242 | James Hardie Industries Plc
Form 20-F
Filed on 18-May-2017 Period 31-Mar-2017 Accession number: 0001193125-17-174339
Included Items
1. 20-F 2. EX-8.1 3. EX-12.1 4. EX-12.2 5. EX-13.1 6. EX-15.1 7. EX-15.2 8. XBRL (render)
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FOR... |
1 | 171902242_1 | 171902242 | SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report For the transition period from to Commission file number 1-15240
JAMES HARDIE INDUSTRIES plc
(Exact name of Registrant as specified in its charter)
N/A (Translation of Registrant's name into English)
Ireland (Jurisdiction of incorpora... |
1 | 171902242_2 | 171902242 | not for trading, but only in connection with the registered American Depositary Shares, pursuant to the requirements of the Securities and Exchange Commission
Table of Contents
Securities registered or to be registered pursuant to Section 12(g) of the Act. None
Securities for which there is a reporting obligation p... |
1 | 171902242_3 | 171902242 | required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the reg... |
1 | 171902242_b0 | 171902242 | Percentage of gross sales individually account for one customer
10.00% 10.00% 10.00%
Number of customer
1
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Segment Reporting Information [Line Items]
Concentration risk, percentage
9.10%
8.10%
Net Sales [Member] | Geographic Concentration Risk ... |
1 | 171902242_b1 | 171902242 | 3
Research and Development [Member]
Segment Reporting Information [Line Items]
Research and development costs
22.6
21.7
24.2
Selling, general and administrative expenses
2.9
2.2
1.8
AICF Funding [Member]
Segment Reporting Information [Line Items]
Net interest (expense) income
1.1
0.3
(1.4)
Australian P... |
1 | 171909496_0 | 171909496 | PERRIGO Co Plc
Form 10-K
Filed on 22-May-2017 Period 31-Dec-2016 Accession number: 0001585364-17-000071
Included Items
1. 10-K 2. EX-10.5: EXHIBIT 10.5 3. EX-10.6: EXHIBIT 10.6 4. EX-10.9: EXHIBIT 10.9 5. EX-10.49: EXHIBIT 10.49 6. EX-10.61: EXHIBIT 10.61 7. EX-21: EXHIBIT 21 8. EX-23: EXHIBIT 23 9. EX-31: EXHIBIT 31... |
1 | 171909496_1 | 171909496 | SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____
Commission file number 001-36353
Perrigo Company plc
(Exact name of registrant as specified in its charter)
Ireland (State or other jurisdiction of incorporation or organization)
N/A (I.R.S. Employer Identificati... |
1 | 171909496_2 | 171909496 | reports pursuant to Section 13 of Section 15(d) of the Act.
YES [ ] NO [X]
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was req... |
1 | 171909496_3 | 171909496 | rant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form10-K or any amendment to
this Form10-K.
[ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an e... |
1 | 171909496_b0 | 171909496 | Royalty Pharma | Subsequent Event Subsequent Event [Line Items] Subsequent event date Sale price of divestiture - cash plus non-cash
Proceeds from sale of business Proceeds from sale of business, maximum milestone payments in year two Proceeds from sale of business, maximum milestone payments in year four Strides Shas... |
1 | 171909496_b1 | 171909496 | of $15.6 million. [7] (4) Includes acquisition costs of $18.5 million, an initial payment made in connection with an R&D agreement of $18.0 million, an inventory step up related to the Omega acquisition totaling $15.6
million, and $13.4 million of Mylan defense-related fees. [8] Includes losses on derivatives associat... |
1 | 171914562_0 | 171914562 | BT GROUP PLC
Form 20-F
Filed on 25-May-2017 Period 31-Mar-2017 Accession number: 0001193125-17-182522
Included Items
1. 20-F 2. EX-4.5 3. EX-4.6 4. EX-7.1 5. EX-12.1 6. EX-12.2 7. EX-13.1 8. EX-15.1 9. EX-15.2 10. EX-15.3
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FO... |
1 | 171914562_1 | 171914562 | SUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
For the transition period from
to
Commission File Number: 1-08819
BT Group plc
(Exact name of Registrant as specified in its charter)
Not Applicable
(Translation of Registrant's name into English)... |
1 | 171914562_2 | 171914562 | pursuant to Section 15(d) of the Act: None
Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the Annual Report:
9,968,127,681 Ordinary Shares, of 5p each
Indicate by check mark if the registrant is a well-known seasoned issu... |
1 | 171914562_3 | 171914562 | for the past 90 days.
Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or ... |
1 | 171914562_b0 | 171914562 | under review annually in accordance with the new auditor rotation rules in the United Kingdom. In its annual review, the Audit & Risk Committee recommended to the Board that the audit tender process be undertaken in 2017/18 with a view to appointing new auditors for the financial year 2018/19.
PwC advised the Audit & ... |
1 | 171914562_b1 | 171914562 |
Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549
25 May 2017
Commissioners:
We have read the statements made by BT Group plc (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 16F of Form 20-F, as part of the Form 20-F of BT Group ... |
1 | 171950131_0 | 171950131 | Castle Brands Inc
Form 10-K
Filed on 14-Jun-2017 Period 31-Mar-2017 Accession number: 0001493152-17-006635
Included Items
1. 10-K 2. EX-10.1 3. EX-10.2 4. EX-10.18 5. EX-10.29 6. EX-21.1 7. EX-23.1 8. EX-31.1 9. EX-31.2 10. EX-32.1 11. XBRL (render)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. ... |
1 | 171950131_1 | 171950131 | charter)
Florida (State or other jurisdiction of incorporation or organization)
41-2103550 (I.R.S. Employer Identification No.)
122 East 42nd Street, Suite 5000 NewYork, NewYork
(Address of principal executive offices)
10168 (Zip Code)
Registrant's telephone number, including area code (646) 356-0200
Securities ... |
1 | 171950131_2 | 171950131 | Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporat... |
1 | 171950131_3 | 171950131 | "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
[ ] Large accelerated filer [ ] Non-accelerated filer [ ] Emerging growth company
[X] Accelerated filer [ ] Smaller reporting company
If an emerging growth company, indicate by check mark if the regist... |
1 | 171950131_b0 | 171950131 | 570 21,572,789
Net (loss) income
699,725 892,364 (489,854) (595,703) 421,406 (595,911) (682,057) (850,144) 506,532 (1,706,706) (3,473,913)
Net (income) loss attributable to noncontrolling interests
(508,375)
(469,798)
(210,856)
(170,116)
4,862
(211,792) (329,214) (273,518) 1,359,145 809,662 325,829
Net (loss)... |
1 | 171950131_b1 | 171950131 | )
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
3 Months Ended
Jun. 30, Mar. 31, Dec. 31,
2016
2016
2015
Sep. 30, 2015
12 Months Ended
Jun. 30, Mar. 31, Mar. 31, Mar. 31, 2015 2017 2016 2015
Quarterly Financial Information Disclosure [Abstract]
Sales, net
$
$
$
$
$
$
$
$
22,580,876 18,309,539 19,627,79... |
1 | 171967363_0 | 171967363 | Medtronic Plc
Form 10-K
Filed on 27-Jun-2017 Period 28-Apr-2017 Accession number: 0001613103-17-000018
Included Items
1. 10-K 2. EX-10.109: EXHIBIT 10.109 3. EX-12.1: COMPUTATION OF RATIO OF
EARNINGS TO FIXED CHARGES 4. EX-21: LIST OF SUBSIDIARIES 5. EX-23: CONSENT OF INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM 6. ... |
1 | 171967363_1 | 171967363 |
Washington, D.C. 20549
FORM 10-K
x
Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934.
For the fiscal year ended April 28, 2017.
o
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
For the transition period from __________ to __________
C... |
1 | 171967363_2 | 171967363 | is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o
Name of each exchange on which registered NewYork Stock Exchange, Inc.
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. Yes o No x
Indicate by check ... |
1 | 171967363_3 | 171967363 | is not contained herein, and will not be contained, to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x
Indicate by check mark whether the registrant is a large accelerated filer, an acce... |
1 | 171967363_b0 | 171967363 | 5,406) 9,924 (3,302) 0 0 (14) (1,110)
(22) 7 0 0
(3,011) 0 0 0 (2,861) (4,005) 5,679 82 (4,131) 113 (1,014) 3,682 $ 2,668
5,966 (353) 2,200 1,139
3,339
4,596
(5,624) (570) (7,582) 5,890 (10,626)
0 89 (18,423)
(85) (1) 0 0 19,942 (1,217) (902) 477 (1,620) 59 (1,100) 937 (31) 16,459 (353) 2,279 1,403 $ 3,682
Schedule ... |
1 | 171967363_b1 | 171967363 | (maturities greater than 90 days) (2)
Proceeds fromshort-termborrowings (maturities greater than 90 days) 12
Issuance of long-term debt
290
Payments on long-term debt
(863)
Dividends to shareholders
0
Issuance of ordinary shares
0
Repurchase of ordinary shares
0
Net intercompany loan borrowings (repayments... |
1 | 171971250_0 | 171971250 | Modern Media Acquisition Corp.
Form 10-K
Filed on 29-Jun-2017 Period 31-Mar-2017 Accession number: 0001193125-17-217854
Included Items
1. 10-K: FORM 10-K 2. EX-31.1 3. EX-31.2 4. EX-32.1 5. EX-32.2
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
ANN... |
1 | 171971250_1 | 171971250 | incorporation)
47-1277598
(IRS Employer Identification No.)
1180 Peachtree Street, N.E. Suite 2400 Atlanta, GA
(Address of principal executive offices)
30309
(Zip Code)
Registrant's telephone number, including area code: (404) 443-1182
None
(Former name or former address, if changed since last report.)
Securitie... |
1 | 171971250_2 | 171971250 | as defined in Rule 405 of the Securities Act. YES NO
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. YES NO
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exc... |
1 | 171971250_3 | 171971250 | knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging g... |
1 | 171971250_b0 | 171971250 | 1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Modern Media Acquisition Corp. (the "Company") for the year ended March 31, 2017, as filed with the Securities and Exchange Commission (the "Report... |
1 | 171971250_b1 | 171971250 | such evaluation and
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to ma... |
1 | 172027612_0 | 172027612 | Seagate Technology Plc
Form 10-K
Filed on 04-Aug-2017 Period 30-Jun-2017 Accession number: 0001193125-17-248796
Included Items
1. 10-K: FORM 10-K 2. EX-21.1 3. EX-23.1 4. EX-31.1 5. EX-31.2 6. EX-32.1 7. XBRL (render)
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 1... |
1 | 172027612_1 | 172027612 | (State or other jurisdiction of incorporation or organization)
38/39 Fitzwilliam Square Dublin 2, Ireland
(Address of principal executive offices)
Registrant's telephone number, including area code: (353) (1) 234-3136
98-0648577 (I.R.S. Employer Identification Number)
Securities registered pursuant to Section 12 (b)... |
1 | 172027612_2 | 172027612 | (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES NO
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, ifany, every Interactive Data File re... |
1 | 172027612_3 | 172027612 | filer" and " smaller reporting company" in Rule 12b-2 ofthe Exchange Act. (Check one):
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check ifa smaller reporting company)
Smaller reporting company
Emerging growth company
Ifan emerging growth company, indicate by check mark ifth... |
1 | 172027612_b0 | 172027612 | years
Guarantees (Product Warranty) (Details) - USD ($)
$ in Millions
12 Months Ended Jun. 30, 2017 Jul. 01, 2016 Jul. 03, 2015 Jun. 27, 2014
Guarantees [Abstract]
Balance, beginning of period
$ 233
$ 206
$ 248
$ 273
Warranties issued
131
125
147
Repairs and replacements
114
152
187
Changes in liabil... |
1 | 172027612_b1 | 172027612 | Unconditional Purchase Obligation, Due after Three Years
0
Capital Addition Purchase Commitments [Member]
Capital Expenditures [Abstract]
Long-term purchase commitment, amount
$ 107,000,000
Commitments (Future minimum lease payments for operating leases) (Details)
$ in Millions
Jun. 30, 2017 USD ($)
Commitmen... |
1 | 172041076_0 | 172041076 | CIMPRESS N.V.
Form 10-K
Filed on 11-Aug-2017 Period 30-Jun-2017 Accession number: 0001262976-17-000025
Included Items
1. 10-K 2. EX-21.1: EXHIBIT 21.1 SUBSIDIARIES OF
CIMPRESS N.V. 3. EX-23.1: EXHIBIT 23.1
PRICEWATERHOUSECOOPERS LLP CONSENT 4. EX-31.1: EXHIBIT 31.1 CERTIFICATION OF
CEO 5. EX-31.2: EXHIBIT 31.2 CERTIF... |
1 | 172041076_1 | 172041076 | 15(d) OFTHESECURITIES EXCHANGEACT OF1934
For the fiscal year ended June 30, 2017
or
o
TRANSITIONREPORT PURSUANT TOSECTION13 OR15(d) OFTHESECURITIES EXCHANGEACT OF1934
For the transition period from
to
Commission file number 000-51539
_________________________________
Cimpress N.V.
(Exact Name of Registrant as Sp... |
1 | 172041076_2 | 172041076 | 12(g) of the Act: None
_________________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes þ No o
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Excha... |
1 | 172041076_3 | 172041076 | of delinquent filers pursuant to Item405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form10-K or any amendment to this Form10-K. o
Indicate by check mark whe... |
1 | 172041076_b0 | 172041076 | 479,205 436,817 496,274 375,748 2,135,405 1,788,044 1,494,206
Cost of revenue
279,077 [1] 268,482 [1] 276,366 [1] 213,050 [1] 222,097 [1] 196,911 [1] 197,462 [1] 157,170 [1] 1,036,975 [2] 773,640 [2] 568,572 [2]
Net (loss) income
(34,513) (42,678) 35,022 (30,030) 17,169 (35,771) 58,991 10,022 (72,199) 50,411 89,31... |
1 | 172041076_b1 | 172041076 | 2] Non-cash charges include acceleration of share-based compensation expenses, as well as abandonment charges for production equipment. [3] Includes restructuring charges for third party professional fees of $2,049, as well as $611 for the abandonment of production equipment which was not
yet placed into service and un... |
1 | 172074529_0 | 172074529 | Atlassian Corp Plc
Form 20-F
Filed on 01-Sep-2017 Period 30-Jun-2017 Accession number: 0001650372-17-000022
Included Items
1. 20-F 2. EX-12.1: EXHIBIT 12.1 3. EX-12.2: EXHIBIT 12.2 4. EX-12.3: EXHIBIT 12.3 5. EX-13.1: EXHIBIT 13.1 6. EX-13.2: EXHIBIT 13.2 7. EX-13.3: EXHIBIT 13.3 8. EX-21.1: EXHIBIT 21.1 9. EX-23.1: ... |
1 | 172074529_1 | 172074529 | d) OF THESECURITIES EXCHANGEACT OF 1934
For the fiscal year ended June 30, 2017
OR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR15(d) OF THESECURITIES EXCHANGEACT OF 1934
OR
¨ SHELLCOMPANYREPORT PURSUANT TO SECTION 13 OR15(d) OF THESECURITIES EXCHANGEACT OF 1934
Commission File Number 001-37651
Atlassian Corporation Pl... |
1 | 172074529_2 | 172074529 | b) of the Act:
Title of each class
Name of each exchange on which registered
Class A Ordinary Shares
NASDAQ Global Select Market
Securities registered or to be registered pursuant to Section 12(g) of the Act: None Securities for whichthere is a reporting obligationpursuant to Section15(d) of the Act: Class B Ordin... |
1 | 172074529_3 | 172074529 | Securities Exchange Act of1934 fromtheir obligations under those Sections. Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) ofthe Securities Exchange Act of1934 during the preceding 12 months (or for such shorter period that the registrant was required... |
1 | 172074529_b0 | 172074529 |
ATLASSIAN CORPORATION PLC
By: /s/ MURRAY J. DEMO
Name:
Murray J. Demo
Title:
Chief Financial Officer
EXHIBIT 21.1
Subsidiaries of Atlassian Corporation Plc
Atlassian Corporation Plc is a holding company and we conduct substantially all of our business through certain of our subsidiaries. As of June 30, 2017, ... |
1 | 172074529_b1 | 172074529 | s/ SCOTT FARQUHAR
Name:
Scott Farquhar
Title:
Co-Chief Executive Officer
EXHIBIT 13.3
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Atlassian Corporation Plc (the "Company... |
1 | 172201685_0 | 172201685 | Adient Plc
Form 10-K
Filed on 22-Nov-2017 Period 30-Sep-2017 Accession number: 0001670541-17-000071
Included Items
1. 10-K 2. EX-10.20: EXHIBIT 10.20 3. EX-21.1: EXHIBIT 21.1 4. EX-23.1: EXHIBIT 23.1 5. EX-31.1: EXHIBIT 31.1 6. EX-31.2: EXHIBIT 31.2 7. EX-32.1: EXHIBIT 32.1 8. XBRL (render)
UNITED STATES SECURITIES... |
1 | 172201685_1 | 172201685 | File Number: 001-37757
Adient plc (exact name of Registrant as specified in its charter)
Ireland
98-1328821
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
25-28 North Wall Quay, IFSC, Dublin 1, Ireland
(Address of principal executive offices)
Registrant's te... |
1 | 172201685_2 | 172201685 | the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Exchange Act from their obligations under those Sections.
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of ... |
1 | 172201685_3 | 172201685 | contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K.
x
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or ... |
1 | 172201685_b0 | 172201685 | Method Investments Summarized Financial Information Operating Income (Loss)
728
663
397
Equity Method Investments Summarized Financial Information Net Income (Loss) Including Noncontrolling Interests
688
625
376
Equity Method Investments Summarized Financial Information Net Income (Loss) Attributable to Noncon... |
1 | 172201685_b1 | 172201685 | Summarized Financial Information, Revenue
12,645 11,928 5,594
Equity Method Investment, Summarized Financial Information, Current Assets
4,661
3,829
Equity Method Investment, Summarized Financial Information, Noncurrent Assets
2,479
2,120
Equity Method Investment, Summarized Financial Information, Assets
7,14... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.